Search Results

SCIEX, a global leader in life science analytical technologies, announced the closing of its acquisition of Intabio, Inc., a privately held company and the developer of the Blaze™ System for biotherapeutic analysis and quality assessment

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio’s Blaze system.

Intabio, Inc. and Protein Metrics Inc., developers of advanced analytical tools for accelerating biopharmaceutical development and manufacturing, today announced a co-development and co-marketing agreement to couple Intabio’s Blaze™ instrument system with the Byos® software suite from Protein Metrics

SCIEX, a global leader in life science analytical technologies, and Intabio, a developer of innovative instrumentation systems for biotherapeutic precision analysis and quality assessment, announced a collaboration to couple Intabio’s Blaze™ system with SCIEX high resolution accurate mass (HRAM) systems.

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio’s microfluidic technology for iCIEF and iCIEF-MS.

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces a co-marketing and equipment loan agreement with Agilent Technologies Inc. to support development of integrated iCIEF-MS assays by interfacing Intabio’s Blaze

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces commercial availability of the Blaze System. Blaze addresses a critical bottleneck for biopharmaceutical developers by identifying unwanted structural modificat

Intabio, Inc., a developer of analytical solutions that provides profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio’s Blaze system. The presentations all are associated with the 17

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announced the launch of its new website providing fresh information about Intabio’s Blaze™ iCIEF-MS system. The new website features updated product information and a detail

Intabio, Inc. announced a publication in Electrophoresis that provides the first in-depth description of Intabio’s Blaze imaged capillary isoelectric focusing – mass spectrometry system and its ability to quickly characterize and identify intact protein charge variants.